Position in SABS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,981,021
+$3,824,224 QoQ
Shares Held
1,277,185
+322.9% QoQ
Ownership
1.40%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 86 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. SABS ranks #242 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SABS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,981,021 | 1,277,185 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,156,797 | 302,036 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $446,992 | 119,517 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $172,292 | 85,718 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $148,774 | 84,772 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $115,171 | 84,685 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $304,407 | 80,234 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $182,363 | 67,542 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $184,186 | 59,415 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $288,135 | 63,466 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $245,178 | 356,364 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $224,509 | 356,364 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $249,439 | 300,529 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $132,232 | 300,529 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $177,312 | 300,529 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $221,980 | 316,663 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $459,161 | 316,663 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,132,173 | 301,110 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,291,500 | 293,406 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||